{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:59:42Z","timestamp":1791053982128,"version":"4.1.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s13555-022-00799-7","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T17:02:32Z","timestamp":1663434152000},"page":"2233-2247","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Comorbidities in Androgenetic Alopecia: A Comprehensive Review"],"prefix":"10.1007","volume":"12","author":[{"given":"Shuang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,17]]},"reference":[{"issue":"3","key":"799_CR1","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1046\/j.1365-2133.1999.03030.x","volume":"141","author":"TF Cash","year":"1999","unstructured":"Cash TF. The psychosocial consequences of androgenetic alopecia: a review of the research literature. Br J Dermatol. 1999;141(3):398\u2013405.","journal-title":"Br J Dermatol"},{"key":"799_CR2","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/bjd.16808","volume":"179","author":"F Rajabi","year":"2018","unstructured":"Rajabi F, Drake LA, Senna MM, Rezaei N. Alopecia areata: a review of disease pathogenesis. Br J Dermatol. 2018;179:1033\u201348.","journal-title":"Br J Dermatol"},{"issue":"4","key":"799_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13799","volume":"33","author":"LT Elsaie","year":"2020","unstructured":"Elsaie LT, Elshahid AR, Hasan HM, et al. Cross sectional quality of life assessment in patients with androgenetic alopecia. Dermatol Ther. 2020;33(4): e13799.","journal-title":"Dermatol Ther"},{"key":"799_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s13555-018-0233-6","volume":"8","author":"E Sorbellini","year":"2018","unstructured":"Sorbellini E, Pinto D, Marzani B, Rinaldi F. Drug treatment for androgenetic alopecia: first Italian questionnaire survey on what dermatologists think about finasteride. Dermatol Ther. 2018;8:259\u201367.","journal-title":"Dermatol Ther"},{"issue":"7","key":"799_CR5","doi-asserted-by":"publisher","first-page":"13030","DOI":"10.5070\/D3247040910","volume":"24","author":"RL Girijala","year":"2018","unstructured":"Girijala RL, Riahi RR, Cohen PR. Platelet-rich plasma for androgenic alopecia treatment: a comprehensive review. Dermatol Online J. 2018;24(7):13030.","journal-title":"Dermatol Online J"},{"key":"799_CR6","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.13005\/bpj\/1224","volume":"10","author":"AA Kubanovl","year":"2017","unstructured":"Kubanovl AA, Gallyamova YA, Korableva OA. The study of growth factors in patients with androgenic alopecia. Biomed Pharmacol J. 2017;10:1219\u201328.","journal-title":"Biomed Pharmacol J."},{"key":"799_CR7","first-page":"1412","volume":"9","author":"ES Schweiger","year":"2010","unstructured":"Schweiger ES, Boychenko O, Bernstein RM. Update on the pathogenesis, genetics and medical treatment of patterned hair loss. J Drugs Dermatol. 2010;9:1412\u20139.","journal-title":"J Drugs Dermatol"},{"key":"799_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12020-017-1280-y","volume":"57","author":"F Lolli","year":"2017","unstructured":"Lolli F, Pallotti F, Rossi A, Fortuna MC, Caro G, Lenzi A, et al. Androgenetic alopecia: a review. Endocrine. 2017;57:9\u201317.","journal-title":"Endocrine"},{"key":"799_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.mehy.2017.12.027","volume":"111","author":"RS English","year":"2018","unstructured":"English RS. A hypothetical pathogenesis model for androgenic alopecia: clarifying the dihydrotestosterone paradox and rate-limiting recovery factors. Med Hypotheses. 2018;111:73\u201381.","journal-title":"Med Hypotheses"},{"key":"799_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.bbrc.2016.02.099","volume":"472","author":"M Sasaki","year":"2016","unstructured":"Sasaki M, Shinozaki S, Shimokado K. Sulforaphane promotes murine hair growth by accelerating the degradation of dihydrotestosterone. Biochem Biophys Res Commun. 2016;472:250\u20134.","journal-title":"Biochem Biophys Res Commun"},{"key":"799_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/09546634.2019.1595507","volume":"31","author":"IG Motofei","year":"2020","unstructured":"Motofei IG, Rowland DL, Tampa M, Sarbu MI, Mitran MI, Mitran CI, et al. Finasteride and androgenic alopecia; from therapeutic options to medical implications. J Dermatolog Treat. 2020;31:415\u201321.","journal-title":"J Dermatolog Treat"},{"key":"799_CR12","first-page":"1","volume":"20","author":"AK Gupta","year":"2021","unstructured":"Gupta AK, Talukder M, Venkataraman M, Bamimore MA. Minoxidil: a comprehensive review. J Dermatol Treat. 2021;20:1\u201311.","journal-title":"J Dermatol Treat"},{"key":"799_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.617395","volume":"11","author":"MF Casanova","year":"2020","unstructured":"Casanova MF, Frye RE, Gillberg C, Casanova EL. Editorial: comorbidity and autism spectrum disorder. Front Psych. 2020;11: 617395.","journal-title":"Front Psych"},{"issue":"2","key":"799_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/ijd.13843","volume":"57","author":"KSJC Bo-Kyung","year":"2018","unstructured":"Bo-Kyung KSJC, Hee-Chul C, Sung-Soo O, Won-Soo L. Gender-specific risk factors for androgenetic alopecia in the Korean general population: associations with medical comorbidities and general health behaviors. Int J Dermatol. 2018;57(2):183\u201392.","journal-title":"Int J Dermatol"},{"key":"799_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.5021\/ad.2018.30.2.251","volume":"30","author":"HC Chung","year":"2018","unstructured":"Chung HC, Choe SJ, Lee S, Oh SS, Lee WS. Medical comorbidities and the onset of androgenetic alopecia: a population-based, case-control study. Ann Dermatol. 2018;30:251\u20132.","journal-title":"Ann Dermatol"},{"key":"799_CR16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1684\/ejd.2014.2346","volume":"24","author":"V Descamps","year":"2014","unstructured":"Descamps V, Mahe E, Maccari F, Begon E, Barthelemy H, Reguiai Z, et al. Severe androgenetic alopecia as a proxy of metabolic syndrome in male psoriatic patients older than 59 years. Eur J Dermatol. 2014;24:356\u201360.","journal-title":"Eur J Dermatol"},{"issue":"3","key":"799_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1590\/S0365-05962012000300010","volume":"87","author":"VSCFR Juliano","year":"2012","unstructured":"Juliano VSCFR, Fernanda HddS, Elisa BDS, Fernanda RLB. Hair loss perception and symptoms of depression in female outpatients attending a general dermatology clinic. An Bras Dermatol. 2012;87(3):412\u20137.","journal-title":"An Bras Dermatol"},{"key":"799_CR18","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jaad.2018.07.013","volume":"80","author":"S Lee","year":"2019","unstructured":"Lee S, Lee H, Lee CH, Lee WS. Comorbidities in alopecia areata: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80:466-477.e416.","journal-title":"J Am Acad Dermatol"},{"key":"799_CR19","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1111\/jdv.16727","volume":"34","author":"RZ Conic","year":"2020","unstructured":"Conic RZ, Tamashunas NL, Damiani G, Fabbrocini G, Cantelli M, Bergfeld WF. Comorbidities in pediatric alopecia areata. J Eur Acad Dermatol Venereol. 2020;34:2898\u2013901.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"799_CR20","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/ced.14507","volume":"46","author":"A Egeberg","year":"2021","unstructured":"Egeberg A, Anderson S, Edson-Heredia E, Burge R. Comorbidities of alopecia areata: a population-based cohort study. Clin Exp Dermatol. 2021;46:651\u20136.","journal-title":"Clin Exp Dermatol"},{"key":"799_CR21","doi-asserted-by":"publisher","first-page":"528","DOI":"10.4103\/ijdvl.IJDVL_671_17","volume":"84","author":"K Vinay","year":"2018","unstructured":"Vinay K, Sawatkar GU, Dogra S. Hair manifestations of endocrine diseases: a brief review. Indian J Dermatol Venereol Leprol. 2018;84:528\u201338.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"799_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.beem.2006.02.004","volume":"20","author":"BO Yildiz","year":"2006","unstructured":"Yildiz BO. Diagnosis of hyperandrogenism: clinical criteria. Best Pract Res Clin Endocrinol Metab. 2006;20:167\u201376.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"799_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s40618-021-01591-8","volume":"45","author":"A Gambineri","year":"2021","unstructured":"Gambineri A, Trimarchi F. Endo&Art why Diana is depicted with mild androgenic alopecia? J Endocrinol Invest. 2021;45(1):229\u201330.","journal-title":"J Endocrinol Invest"},{"key":"799_CR24","first-page":"84","volume":"12","author":"CM Clark","year":"2014","unstructured":"Clark CM, Rudolph J, Gerber DA, Glick S, Shalita AR, Lowenstein EJ. Dermatologic manifestation of hyperandrogenism: a retrospective chart review. Skinmed. 2014;12:84\u20138.","journal-title":"Skinmed"},{"key":"799_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/09513590.2016.1252326","volume":"33","author":"A Guarino","year":"2017","unstructured":"Guarino A, Di Benedetto L, Giovanale V, Vinciguerra GLR, Stoppacciaro A, Bellati F, et al. Hyperandrogenism in a postmenopausal woman: a rare case of ectopic adrenal cortical gland. Gynecol Endocrinol. 2017;33:185\u20137.","journal-title":"Gynecol Endocrinol"},{"key":"799_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1089\/gyn.2017.0038","volume":"34","author":"TM Roth","year":"2018","unstructured":"Roth TM. Postmenopausal ovarian hyperthecosis associated with rapid testosterone excess. J Gynecol Surg. 2018;34:36\u20139.","journal-title":"J Gynecol Surg"},{"key":"799_CR27","doi-asserted-by":"crossref","unstructured":"\u00d6zdemir S, \u00d6zdemir M, Gorkemli H, Kiyici A, Bodur S. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism. 2010;89:199\u2013204.","DOI":"10.3109\/00016340903353284"},{"key":"799_CR28","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/jocd.12387","volume":"17","author":"JG Feng","year":"2018","unstructured":"Feng JG, Guo Y, Ma LA, Xing J, Sun RF, Zhu W. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China. J Cosmet Dermatol. 2018;17:511\u20137.","journal-title":"J Cosmet Dermatol"},{"key":"799_CR29","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.fertnstert.2014.01.003","volume":"101","author":"M Quinn","year":"2014","unstructured":"Quinn M, Shinkai K, Pasch L, Kuzmich L, Cedars M, Huddleston H. Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features. Fertil Steril. 2014;101:1129\u201334.","journal-title":"Fertil Steril"},{"key":"799_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.14341\/probl12732","volume":"67","author":"VA Filatova","year":"2021","unstructured":"Filatova VA, Rozhivanov RV. Features of hyperandrogenism in men. Problemy Endokrinologii. 2021;67:111\u20135.","journal-title":"Problemy Endokrinologii"},{"key":"799_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.12737\/article_5a3a0d5360f938.91867142","volume":"2","author":"LV Belenkaya","year":"2017","unstructured":"Belenkaya LV, Ivanov OV, Panarina OV, Rashidova MA, Sholokhov LF. Trichology features of alopecia in reproductive age women with polycystic ovary syndrome. Acta Biomedica Scientifica (East Siberian Biomed J). 2017;2:9\u201314.","journal-title":"Acta Biomedica Scientifica (East Siberian Biomed J)"},{"key":"799_CR32","first-page":"591","volume":"13","author":"A Jalilian","year":"2015","unstructured":"Jalilian A, Kiani F, Sayehmiri F, Sayehmiri K, Khodaee Z, Akbari M. Prevalence of polycystic ovary syndrome and its associated complications in Iranian women: a meta-analysis. Iran J Reprod Med. 2015;13:591\u2013604.","journal-title":"Iran J Reprod Med"},{"key":"799_CR33","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0002-9378(15)33704-2","volume":"100","author":"HE Cooper","year":"1968","unstructured":"Cooper HE, Spellacy WN, Prem KA, Cohen WD. Hereditary factors in the Stein-Leventhal syndrome. Am J Obstet Gynecol. 1968;100:371\u201387.","journal-title":"Am J Obstet Gynecol"},{"key":"799_CR34","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1001\/jamadermatol.2016.1776","volume":"152","author":"S Sanke","year":"2016","unstructured":"Sanke S, Chander R, Jain A, Garg T, Yadav P. A comparison of the hormonal profile of early androgenetic alopecia in men with the phenotypic equivalent of polycystic ovarian syndrome in women. JAMA Dermatol. 2016;152:986\u201391.","journal-title":"JAMA Dermatol"},{"key":"799_CR35","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.jfma.2019.04.013","volume":"118","author":"YA Tu","year":"2019","unstructured":"Tu YA, Lin SJ, Chen PL, Chou CH, Huang CC, Ho HN, et al. HSD3B1 gene polymorphism and female pattern hair loss in women with polycystic ovary syndrome. J Formos Med Assoc. 2019;118:1225\u201331.","journal-title":"J Formos Med Assoc"},{"key":"799_CR36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/jamadermatol.2015.4498","volume":"152","author":"TH Schmidt","year":"2016","unstructured":"Schmidt TH, Khanijow K, Cedars MI, Huddleston H, Pasch L, Wang ET, et al. Cutaneous findings and systemic associations in women with polycystic ovary syndrome. JAMA Dermatol. 2016;152:391\u20138.","journal-title":"JAMA Dermatol"},{"key":"799_CR37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s13300-017-0348-2","volume":"9","author":"R Rodr\u00edguez-Guti\u00e9rrez","year":"2018","unstructured":"Rodr\u00edguez-Guti\u00e9rrez R, Salcido-Montenegro A, Gonz\u00e1lez-Gonz\u00e1lez JG. Early clinical expressions of insulin resistance: the real enemy to look for. Diabetes Ther. 2018;9:435\u20138.","journal-title":"Diabetes Ther"},{"key":"799_CR38","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1097\/PRS.0b013e31826d104f","volume":"130","author":"J Gatherwright","year":"2012","unstructured":"Gatherwright J, Liu MT, Gliniak C, Totonchi A, Guyuron B. The contribution of endogenous and exogenous factors to female alopecia: a study of identical twins. Plast Reconstr Surg. 2012;130:1219\u201326.","journal-title":"Plast Reconstr Surg"},{"key":"799_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4103\/jrms.JRMS_585_20","volume":"26","author":"N Adibi","year":"2021","unstructured":"Adibi N, Robati RM. Skin and metabolic syndrome: a review of the possible associations. J Res Med Sci. 2021;26:16.","journal-title":"J Res Med Sci"},{"key":"799_CR40","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1001\/jamadermatol.2013.130","volume":"149","author":"L-H Su","year":"2013","unstructured":"Su L-H, Chen L-S, Lin S-C, Chen H-H. Association of androgenetic alopecia with mortality from diabetes mellitus and heart disease. JAMA Dermatol. 2013;149:601.","journal-title":"JAMA Dermatol"},{"key":"799_CR41","unstructured":"Jafari F, Nilforooshzade MA, Porajam S, Beni MH. Comparison of androgenic alopecia distribution among type 2 diabetes and healthy women in Isfahan city: a brief report. Tehran Univ Med J. 2014;72."},{"key":"799_CR42","first-page":"168","volume":"42","author":"JB Schmidt","year":"1991","unstructured":"Schmidt JB, Lindmaier A, Spona J. Hyperprolactinemia and hypophyseal hypothyroidism as cofactors in hirsutism and androgen-induced alopecia in women. Hautarzt. 1991;42:168\u201372.","journal-title":"Hautarzt"},{"key":"799_CR43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000211275","volume":"7","author":"JB Schmidt","year":"1994","unstructured":"Schmidt JB. Hormonal basis of male and female androgenic alopecia: clinical relevance. Skin Pharmacol. 1994;7:61\u20136.","journal-title":"Skin Pharmacol"},{"key":"799_CR44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4103\/0974-7753.188033","volume":"8","author":"TW Siah","year":"2016","unstructured":"Siah TW, Muir-Green L, Shapiro J. Female pattern hair loss: a retrospective study in a tertiary referral center. Int J Trichol. 2016;8:57\u201361.","journal-title":"Int J Trichol"},{"key":"799_CR45","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.abd.2021.05.006","volume":"96","author":"K Babaei","year":"2021","unstructured":"Babaei K, Kavoussi H, Rezaei M, Kavoussi R. Characteristics of telogen effluvium in COVID-19 in western Iran (2020). An Bras Dermatol. 2021;96:688\u201392.","journal-title":"An Bras Dermatol"},{"key":"799_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12885-018-4194-z","volume":"18","author":"WJ Liang","year":"2018","unstructured":"Liang WJ, Song LY, Peng Z, Zou Y, Dai SM. Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis. BMC Cancer. 2018;18:11.","journal-title":"BMC Cancer"},{"key":"799_CR47","first-page":"23","volume":"5","author":"GR Rokni","year":"2016","unstructured":"Rokni GR, Gorji AMH, Sharifian M, Talarposhti AHR, Barzgarnejad A. The relationship between androgenic alopecia and prostate cancer. Int J Med Res Health Sci. 2016;5:23\u20139.","journal-title":"Int J Med Res Health Sci"},{"key":"799_CR48","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4103\/ejdv.ejdv_46_19","volume":"40","author":"HN Khaled","year":"2020","unstructured":"Khaled HN, Allah AMA, Abdelhameed AA, Shehata WA. Role of serum androgens and prostate-specific antigen levels in men with androgenetic alopecia. Egypt J Dermat Vener. 2020;40:106\u201311.","journal-title":"Egypt J Dermat Vener"},{"key":"799_CR49","first-page":"154","volume":"40","author":"A Wesolowska","year":"2019","unstructured":"Wesolowska A, Tuszynska A, Szlendak-Sauer K, Smolarczyk R, Grabowska-Derlatka L, Przytula E. Ovarian Leydig cell tumour in a postmenopausal woman with alopecia. Eur J Gynaecol Oncol. 2019;40:154\u20136.","journal-title":"Eur J Gynaecol Oncol"},{"key":"799_CR50","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jdermsci.2013.12.005","volume":"74","author":"LM Sun","year":"2014","unstructured":"Sun LM, Lin MC, Muo CH, Liang JA, Sung FC, Kao CH. Women with alopecia exhibit a higher risk for thyroid cancer: a nationwide cohort study. J Dermatol Sci. 2014;74:18\u201322.","journal-title":"J Dermatol Sci"},{"key":"799_CR51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/bcr-2020-240937","volume":"14","author":"C Ferrinho","year":"2021","unstructured":"Ferrinho C, Silva E, Oliveira M, Duarte JS. Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation. BMJ Case Rep. 2021;14:4.","journal-title":"BMJ Case Rep"},{"key":"799_CR52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.mcna.2017.11.001","volume":"102","author":"WJ Catalona","year":"2018","unstructured":"Catalona WJ. Prostate cancer screening. Med Clin N Am. 2018;102:199\u2013214.","journal-title":"Med Clin N Am"},{"key":"799_CR53","doi-asserted-by":"publisher","first-page":"146","DOI":"10.9734\/jpri\/2021\/v33i30A31625","volume":"33","author":"FH Memon","year":"2021","unstructured":"Memon FH, Rahimoon AG, Kumar P, Memon SH, Siddiqui E, Devrajani T, et al. Androgenetic alopecia as a marker of metabolic syndrome. J Pharm Res Int. 2021;33:146\u201353.","journal-title":"J Pharm Res Int"},{"key":"799_CR54","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4103\/ijem.IJEM_650_17","volume":"22","author":"KC Dharam Kumar","year":"2018","unstructured":"Dharam Kumar KC, Kishan Kumar YH, Neladimmanahally V. Association of androgenetic alopecia with metabolic syndrome: a case-control study on 100 patients in a tertiary care hospital in South India. Indian J Endocrinol Metab. 2018;22:196\u20139.","journal-title":"Indian J Endocrinol Metab"},{"key":"799_CR55","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4103\/0378-6323.174421","volume":"82","author":"H Gopinath","year":"2016","unstructured":"Gopinath H, Upadya GM. Metabolic syndrome in androgenic alopecia. Indian J Dermatol Venereol Leprol. 2016;82:404\u20138.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"799_CR56","first-page":"91","volume":"8","author":"E Behrangi","year":"2018","unstructured":"Behrangi E, Azizian Z, Ardestani FS, Najafi Z, Vakili SH. Association of androgenic alopecia with metabolic syndrome. Ann Med Health Sci Res. 2018;8:91\u20133.","journal-title":"Ann Med Health Sci Res"},{"key":"799_CR57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/ijd.IJD_526_16","volume":"64","author":"RV Vora","year":"2019","unstructured":"Vora RV, Kota R, Singhal RR, Anjaneyan G. Clinical profile of androgenic alopecia and its association with cardiovascular risk factors. Indian J Dermatol. 2019;64:19\u201322.","journal-title":"Indian J Dermatol"},{"key":"799_CR58","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4103\/2229-5178.137776","volume":"5","author":"OA Bakry","year":"2014","unstructured":"Bakry OA, Shoeib MA, El Shafiee MK, Hassan A. Androgenetic alopecia, metabolic syndrome, and insulin resistance: is there any association? A case-control study. Indian Dermatol Online J. 2014;5:276\u201381.","journal-title":"Indian Dermatol Online J"},{"key":"799_CR59","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/jcb.26169","volume":"119","author":"NH Goradel","year":"2018","unstructured":"Goradel NH, Hour FG, Negahdari B, Malekshahi ZV, Hashemzehi M, Masoudifar A, et al. Stem cell therapy: a new therapeutic option for cardiovascular diseases. J Cell Biochem. 2018;119:95\u2013104.","journal-title":"J Cell Biochem"},{"key":"799_CR60","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4103\/mmj.mmj_394_19","volume":"34","author":"S Mohammed","year":"2021","unstructured":"Mohammed S, Ola B, Shimaa S, Amira I. Troponin I in alopecia areata and female pattern hair loss. Menoufia Medical Journal. 2021;34:498.","journal-title":"Menoufia Medical Journal."},{"key":"799_CR61","doi-asserted-by":"publisher","first-page":"25","DOI":"10.21767\/AMJ.2017.3270","volume":"11","author":"M Amamoto","year":"2018","unstructured":"Amamoto M, Yamada T, Hara K. Updated meta-analysis of the relation between heart disease and androgenic alopecia or alopecia areata. Australas Med J. 2018;11:25\u201333.","journal-title":"Australas Med J"},{"key":"799_CR62","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jaad.2009.10.018","volume":"63","author":"S Arias-Santiago","year":"2010","unstructured":"Arias-Santiago S, Guti\u00e9rrez-Salmer\u00f3n MT, Castellote-Caballero L, Buend\u00eda-Eisman A, Naranjo-Sintes R. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study. J Am Acad Dermatol. 2010;63:420\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"799_CR63","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.2147\/IJGM.S326812","volume":"14","author":"YX Wang","year":"2021","unstructured":"Wang YX, Chen XW, Wang SB, Gu LF, Li YF, Ma Y, et al. Association between androgenic alopecia and coronary artery disease: a cross-sectional study of Han Chinese male population. Int J Gen Med. 2021;14:4809\u201318.","journal-title":"Int J Gen Med"},{"issue":"6","key":"799_CR64","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/jdv.14000","volume":"31","author":"MW Kim","year":"2017","unstructured":"Kim MW, Shin IS, Yoon HS, et al. Lipid profile in patients with androgenetic alopecia: a meta-analysis. J Eur Acad Dermatol Venereol JEADV. 2017;31(6):942\u201351.","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"799_CR65","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/XCE.0000000000000136","volume":"6","author":"K Sharma","year":"2017","unstructured":"Sharma K, Humane D, Shah K, Patil S, Charaniya R, Meniya J. Androgenic alopecia, premature graying, and hair thinning as independent predictors of coronary artery disease in young Asian males. Cardiovasc Endocrinol. 2017;6:152\u20138.","journal-title":"Cardiovasc Endocrinol"},{"key":"799_CR66","first-page":"220","volume":"17","author":"S Ahouansou","year":"2007","unstructured":"Ahouansou S, Le Toumelin P, Crickx B, Descamps V. Association of androgenetic alopecia and hypertension. Eur J Dermatol. 2007;17:220\u20132.","journal-title":"Eur J Dermatol"},{"key":"799_CR67","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4103\/1110-6530.123946","volume":"33","author":"EF El","year":"2013","unstructured":"El EF, Ei RS. Androgenetic alopecia as an early marker for hypertension. Egypt J Dermatol Venerol. 2013;33:63.","journal-title":"Egypt J Dermatol Venerol."},{"issue":"4","key":"799_CR68","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1365-2133.2009.09588.x","volume":"162","author":"SS Arias","year":"2010","unstructured":"Arias SS, Gutierrez SMT, Buendia EA, Giron PMS, Naranjo SR. Hypertension and aldosterone levels in women with early-onset androgenetic alopecia. Br J Dermatol. 2010;162(4):786\u20139.","journal-title":"Br J Dermatol"},{"key":"799_CR69","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2147\/CCID.S231940","volume":"13","author":"M Danesh-Shakiba","year":"2020","unstructured":"Danesh-Shakiba M, Poorolajal J, Alirezaei P. Androgenetic alopecia: relationship to anthropometric indices, blood pressure and life-style habits. Clin Cosmet Investig Dermatol. 2020;13:137\u201343.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"799_CR70","first-page":"4","volume":"97","author":"X Wang","year":"2018","unstructured":"Wang X, Xiong CP, Zhang L, Yang B, Wei RF, Cui LQ, et al. Psychological assessment in 355 Chinese college students with androgenetic alopecia. Medicine. 2018;97:4.","journal-title":"Medicine"},{"issue":"8","key":"799_CR71","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/jamadermatol.2021.2196","volume":"157","author":"H ChunHsien","year":"2021","unstructured":"ChunHsien H, Yun F, ChingChi C. Health-related quality of life, depression, and self-esteem in patients with androgenetic alopecia: a systematic review and meta-analysis. JAMA Dermatol. 2021;157(8):963\u201370.","journal-title":"JAMA Dermatol"},{"key":"799_CR72","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1590\/abd1806-4841.20185658","volume":"93","author":"B Tas","year":"2018","unstructured":"Tas B, Kulacaoglu F, Belli H, Altuntas M. The tendency towards the development of psychosexual disorders in androgenetic alopecia according to the different stages of hair loss: a cross-sectional study. An Bras Dermatol. 2018;93:185\u201390.","journal-title":"An Bras Dermatol"},{"key":"799_CR73","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s40257-013-0010-3","volume":"14","author":"S Tabolli","year":"2013","unstructured":"Tabolli S, Sampogna F, di Pietro C, Mannooranparampil TJ, Ribuffo M, Abeni D. Health status, coping strategies, and alexithymia in subjects with androgenetic alopecia: a questionnaire study. Am J Clin Dermatol. 2013;14:139\u201345.","journal-title":"Am J Clin Dermatol"},{"key":"799_CR74","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.genhosppsych.2014.02.008","volume":"36","author":"BY Wu","year":"2014","unstructured":"Wu BY, Wu BJ, Lee SM, Sun HJ, Chang YT, Lin MW. Prevalence and associated factors of comorbid skin diseases in patients with schizophrenia: a clinical survey and national health database study. Gen Hosp Psychiatry. 2014;36:415\u201321.","journal-title":"Gen Hosp Psychiatry"},{"key":"799_CR75","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00403-004-0514-z","volume":"296","author":"WC Chen","year":"2004","unstructured":"Chen WC, Yang CC, Chen GY, Wu MC, Sheu HM, Tzai TS. Patients with a large prostate show a higher prevalence of androgenetic alopecia. Arch Dermatol Res. 2004;296:245\u20139.","journal-title":"Arch Dermatol Res"},{"key":"799_CR76","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/jdv.12468","volume":"29","author":"R Kucerova","year":"2015","unstructured":"Kucerova R, Bienova M, Kral M, Bouchal J, Trtkova KS, Burdova A, et al. Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer. J Eur Acad Dermatol Venereol. 2015;29:91\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"799_CR77","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00240-016-0888-3","volume":"44","author":"EC Polat","year":"2016","unstructured":"Polat EC, Ozcan L, Otunctemur A, Ozbek E. Relation of urinary stone disease with androgenetic alopecia and serum testosterone levels. Urolithiasis. 2016;44:409\u201313.","journal-title":"Urolithiasis"},{"key":"799_CR78","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.aju.2016.01.003","volume":"14","author":"NF Agamia","year":"2016","unstructured":"Agamia NF, Abou Youssif T, El-Hadidy A, El-Abd A. Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: is there a possible relationship? Arab J Urol. 2016;14:157\u201362.","journal-title":"Arab J Urol"},{"key":"799_CR79","first-page":"39","volume":"72","author":"N Aourag","year":"2019","unstructured":"Aourag N, Langenhuijsen JF, d\u2019Ancona F, Heesakkers J. Can we predict prostate size by scoring baldness? The relationship of androgenic alopecia and lower urinary tract symptoms. Central Eur J Urol. 2019;72:39\u201343.","journal-title":"Central Eur J Urol"},{"key":"799_CR80","first-page":"30","volume":"53","author":"L Dastgheib","year":"2015","unstructured":"Dastgheib L, Shirazi M, Moezzi I, Dehghan S, Sadati MS. Is there a relationship between androgenic alopecia and benign prostatic hyperplasia? Acta Med Iran. 2015;53:30\u20132.","journal-title":"Acta Med Iran"},{"key":"799_CR81","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1371\/journal.pone.0079789","volume":"8","author":"CH Lai","year":"2013","unstructured":"Lai CH, Chu NF, Chang CW, Wang SL, Yang HC, Chu CM, et al. Androgenic alopecia is associated with less dietary soy, higher blood vanadium and rs1160312 1 polymorphism in Taiwanese communities. PLoS ONE. 2013;8:11.","journal-title":"PLoS ONE"},{"key":"799_CR82","first-page":"204","volume":"10","author":"M Amirnia","year":"2013","unstructured":"Amirnia M, Sinafar S, Sinafar H, Nuri M, Sadeghi AT. Assessment of zinc and copper contents in the hair and serum and also superoxide dismutase, glutathion peroxidase and malondi aldehyde in serum in androgenetic alopecia and alopecia areata. Life Sci J. 2013;10:204\u20139.","journal-title":"Life Sci J"},{"key":"799_CR83","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/ijt.ijt_48_16","volume":"9","author":"D Gowda","year":"2017","unstructured":"Gowda D, Premalatha V, Imtiyaz DB. Prevalence of nutritional deficiencies in hair loss among Indian participants: results of a cross-sectional study. Int J Trichol. 2017;9:101\u20134.","journal-title":"Int J Trichol"},{"key":"799_CR84","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1007\/s12011-020-02468-2","volume":"199","author":"IN Kondrakhina","year":"2021","unstructured":"Kondrakhina IN, Verbenko DA, Zatevalov AM, Gatiatulina ER, Nikonorov AA, Deryabin DG, et al. A cross-sectional study of plasma trace elements and vitamins content in androgenetic alopecia in men. Biol Trace Elem Res. 2021;199:3232\u201341.","journal-title":"Biol Trace Elem Res"},{"key":"799_CR85","doi-asserted-by":"publisher","first-page":"167","DOI":"10.15690\/vramn1141","volume":"74","author":"IN Kondrakhina","year":"2019","unstructured":"Kondrakhina IN, Verbenko DA, Zatevalov AM, Kubanov AA, Deryabin DG. The value of genetic and non-genetic factors in the emergence and in the development of androgenetic alopecia in men: multifactor analysis. Ann Russian Acad Med Sci. 2019;74:167\u201375.","journal-title":"Ann Russian Acad Med Sci"},{"key":"799_CR86","volume":"27","author":"B Liang","year":"2021","unstructured":"Liang B, Ding Y, Zhou Y, et al. Evaluation of susceptibility genes\/loci associated with male androgenetic alopecia (MAGA) for female-pattern hair loss in a Chinese Han population and a brief literature review. Med Sci Monitor Int Med J Exp Clin Res. 2021;27: e933424.","journal-title":"Med Sci Monitor Int Med J Exp Clin Res"},{"key":"799_CR87","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15187","author":"IY Kim","year":"2022","unstructured":"Kim IY, Kim JH, Choi JE, et al. The first broad replication study of SNPs and a pilot genome-wide association study for androgenetic alopecia in Asian populations. J Cosmet Dermatol. 2022. https:\/\/doi.org\/10.1111\/jocd.15187.","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"799_CR88","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000512865","volume":"7","author":"A Babadjounia","year":"2021","unstructured":"Babadjounia A, Pouldar FD, Hedayati B, et al. The effects of smoking on hair health: a systematic review. Skin Appendage Disord. 2021;7(4):251\u201364.","journal-title":"Skin Appendage Disord"},{"issue":"6","key":"799_CR89","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1111\/j.1365-2133.2003.05565.x","volume":"149","author":"G Severi","year":"2003","unstructured":"Severi G, Sinclair R, Hopper JL, et al. Androgenetic alopecia in men aged 40\u201369 years: prevalence and risk factors. Br J Dermatol. 2003;149(6):1207\u201313.","journal-title":"Br J Dermatol"},{"issue":"8","key":"799_CR90","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/ijd.13652","volume":"56","author":"C Fortes","year":"2017","unstructured":"Fortes C, Mastroeni S, Mannooranparampil TJ, et al. The combination of overweight and smoking increases the severity of androgenetic alopecia. Int J Dermatol. 2017;56(8):862\u20137.","journal-title":"Int J Dermatol"},{"issue":"4","key":"799_CR91","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/jocd.13727","volume":"20","author":"AS Salem","year":"2021","unstructured":"Salem AS, Ibrahim HS, Abdelaziz HH, et al. Implications of cigarette smoking on early-onset androgenetic alopecia: a cross-sectional Study. J Cosmet Dermatol. 2021;20(4):1318\u201324.","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"799_CR92","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1111\/jocd.14373","volume":"21","author":"SME Youssef","year":"2022","unstructured":"Youssef SME, Atallah RB, Zaky MS, et al. Urban-rural differences in the prevalence of female pattern hair loss among secondary school girls: a cross-sectional study. J Cosmet Dermatol. 2022;21(5):2229\u201335.","journal-title":"J Cosmet Dermatol"},{"key":"799_CR93","doi-asserted-by":"publisher","unstructured":"Liamsombut S, Pomsoong C, Kositkuljorn C, et al. Sleep quality in men with androgenetic alopecia. Sleep Breath. 2022. \nhttps:\/\/doi.org\/10.1007\/s11325-022-02618-x.","DOI":"10.1007\/s11325-022-02618-x"},{"issue":"2","key":"799_CR94","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13273","volume":"33","author":"Y Yi","year":"2020","unstructured":"Yi Y, Qiu J, Jia J, et al. Severity of androgenetic alopecia associated with poor sleeping habits and carnivorous eating and junk food consumption-A web-based investigation of male pattern hair loss in China. Dermatol Ther. 2020;33(2): e13273.","journal-title":"Dermatol Ther"},{"issue":"6","key":"799_CR95","first-page":"675","volume":"156","author":"E Agaoglu","year":"2021","unstructured":"Agaoglu E, Kaya EH, Acer E, et al. Prevalence of early-onset androgenetic alopecia and its relationship with lifestyle and dietary habits. Italian J Dermatol Venereol. 2021;156(6):675\u201380.","journal-title":"Italian J Dermatol Venereol"},{"issue":"11","key":"799_CR96","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.7150\/ijms.45979","volume":"17","author":"Y Yi","year":"2020","unstructured":"Yi Y, Li X, Jia J, et al. Effect of behavioral factors on severity of female pattern hair loss: an ordinal logistic regression analysis. Int J Med Sci. 2020;17(11):1584\u20138.","journal-title":"Int J Med Sci"},{"issue":"4","key":"799_CR97","doi-asserted-by":"publisher","DOI":"10.1002\/ski2.72","volume":"1","author":"SK Henne","year":"2021","unstructured":"Henne SK, Hochfeld LM, Maj C, et al. Systematic investigation of a potential epidemiological and genetic association between male androgenetic alopecia and COVID-19. Skin Health Dis. 2021;1(4): e72.","journal-title":"Skin Health Dis"},{"key":"799_CR98","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-022-02981-4","author":"D Veskovic","year":"2022","unstructured":"Veskovic D, Ros T, Icin T, et al. Association of androgenetic alopecia with a more severe form of COVID-19 infection. Ir J Med Sci. 2022. https:\/\/doi.org\/10.1007\/s11845-022-02981-4.","journal-title":"Ir J Med Sci"},{"issue":"2","key":"799_CR99","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jaad.2020.05.079","volume":"83","author":"CG Wambier","year":"2020","unstructured":"Wambier CG, Vano GS, Mccoy J, et al. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: the \u201cGabrin sign.\u201d J Am Acad Dermatol. 2020;83(2):680\u20132.","journal-title":"J Am Acad Dermatol"},{"key":"799_CR100","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jdin.2022.02.006","volume":"7","author":"B Nguyen","year":"2022","unstructured":"Nguyen B, Tosti A. Alopecia in patients with COVID-19: A systematic review and meta-analysis. JAAD Int. 2022;7:67\u201377.","journal-title":"JAAD Int."},{"issue":"3","key":"799_CR101","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/jocd.14683","volume":"21","author":"R Ghafoor","year":"2022","unstructured":"Ghafoor R, Ali SM, Patil A, et al. Association of androgenetic alopecia and severity of coronavirus disease 2019. J Cosmet Dermatol. 2022;21(3):874\u20139.","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"799_CR102","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/jocd.14670","volume":"21","author":"M Baghani","year":"2022","unstructured":"Baghani M, Pourani MR, Nekooghadam SM, et al. Androgenetic alopecia and COVID-19: Is there a clinical connection? J Cosmet Dermatol. 2022;21(2):420\u20135.","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"799_CR103","first-page":"163","volume":"86","author":"B Bevin","year":"2021","unstructured":"Bevin B. A simple technique to distinguish fibrosing alopecia in a pattern distribution from androgenetic alopecia and concomitant seborrheic dermatitis. J Am Acad Dermatol. 2021;86(1):163\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"799_CR104","first-page":"886","volume":"35","author":"S Alan","year":"2014","unstructured":"Alan S, Cenesizoglu E. Effects of hyperandrogenism and high body mass index on acne severity in women. Saudi Med J. 2014;35:886\u20139.","journal-title":"Saudi Med J"},{"key":"799_CR105","doi-asserted-by":"publisher","DOI":"10.5812\/jssc.64187","author":"L Khezrian","year":"2016","unstructured":"Khezrian L, Yazdanfar A, Azizian Z, Hassani P, Feyzian M. The relationship between acne and other hyperandrogenism signs. J Skin Stem Cell. 2016. https:\/\/doi.org\/10.5812\/jssc.64187.","journal-title":"J Skin Stem Cell."},{"key":"799_CR106","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013448","volume":"97","author":"S Portaro","year":"2018","unstructured":"Portaro S, Naro A, Guarneri C, Di Toro G, Manuli A, Calabr\u00f2 RS. Hemangiomas of the tongue and the oral cavity in a myotonic dystrophy type 1 patient: a case report. Medicine (Baltimore). 2018;97: e13448.","journal-title":"Medicine (Baltimore)"},{"key":"799_CR107","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.nmd.2015.02.013","volume":"25","author":"A Campanati","year":"2015","unstructured":"Campanati A, Giannoni M, Buratti L, Cagnetti C, Giuliodori K, Ganzetti G, et al. Skin features in myotonic dystrophy type 1: an observational study. Neuromuscular Disord NMD. 2015;25:409\u201313.","journal-title":"Neuromuscular Disord NMD"},{"key":"799_CR108","first-page":"18","volume":"19","author":"JJC Castrillon","year":"2019","unstructured":"Castrillon JJC, Garcia MCB, Reyn FJB, Valbuena SMG, Urrego LYM, Diaz DAP. Study on hair loss and care practices among students of the Universidad de Manizales, Manizales (Colombia), 2016. Arch Med. 2019;19:18.","journal-title":"Arch Med"},{"key":"799_CR109","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s43440-021-00295-3","volume":"73","author":"R Krysiak","year":"2021","unstructured":"Krysiak R, Kowalcze K, Okopien B. The impact of exogenous vitamin D  on thyroid autoimmunity in euthyroid men with autoimmune thyroiditis and early-onset androgenic alopecia. Pharmacol Rep. 2021;73:1439\u201347.","journal-title":"Pharmacol Rep"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00799-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-022-00799-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00799-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T21:09:43Z","timestamp":1664312983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-022-00799-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,17]]},"references-count":109,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["799"],"URL":"https:\/\/doi.org\/10.1007\/s13555-022-00799-7","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,17]]},"assertion":[{"value":"5 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}